February 27, 2021 | Bern, Switzerland

Update in Genitourinary Cancers

Many thanks to everyone, who attended the virtual ASCO Direct™ GU Highlights Meeting on Saturday, February 27, 2021.

The ASCO Direct GU Highlights Meeting was a full-day educational program containing selected original sessions from the 2021 Genitourinary Cancers Symposium on prostate, penile, testis, renal and bladder cancers. Attendees had the opportunity to view the original sessions with most actual clinical data in uro-oncology and discuss the clinical relevance and implications for Swiss treatment landscape of the presented evidence with their colleagues.

Here are the program and details of the ASCO Direct™ GU Highlights Meeting 2021. We look forward to organizing the ASCO Direct GU Highlights meeting 2022. The related information will be available later this year.

If you would like any further information, please feel free to contact us at asco@springer.com

Independent scientific committee

The program is supervised by an independent scientific committee:

  • Jörg Beyer, Inselspital Bern
  • Thomas Hermanns, Universitätsspital Zürich
  • Aurelius Omlin, Kantonsspital St. Gallen
  • Dominik Berthold, Centre Hospitalier Universitaire Vaudois

Guest speakers

  • Wolfram Jochum, Kantonsspital St. Gallen
  • Thomas Zilli, Hôpitaux Universitaires de Genève


Saturday, 27 February 2021, from 09:00 until 18:00
The program includes educational sessions.

You will be provided with individual access to the ASCO® Meeting Library, so you can review the videos and slides from the ASCO GU symposium after the meeting.

Deviations in the final program are possible (dependent on availability of the video materials)

Benefits of this meeting

  • Discussion with Swiss experts and colleagues
  • Reduced time to stay informed about the latest news and developments presented at the ASCO GU symposium
  • Access to all videos and slides from ASCO GU 2021 via the ASCO® Meeting Library


Please feel free to contact us at asco@springer.com if you have any questions.





ASCO Direct™ Highlights is an officially licensed program of the American Society of Clinical Oncology®. ASCO® is a registered trademark of the American Society of Clinical Oncology. All rights reserved. ASCO does not endorse any health care product, therapy, diagnostic test or device.​

Copyright © 2020 Springer Healthcare Limited. Part of the Springer Nature Group.